Profile
Bain Capital is a global private investment firm that partners with companies to create exceptional outcomes. The firm has a collaborative culture that emphasizes building enduring relationships and leveraging diverse expertise across various sectors. Bain Capital has strategically grown its business over four decades, focusing on value creation and sustainable growth.
The firm invests across multiple sectors, including private equity, growth and venture capital, credit, and real assets. Their investment strategy encompasses various stages and asset types, with a focus on transformative ideas and innovative solutions. Bain Capital's approach includes investing in life sciences, technology, and special situations, among others.
Notable investments include Vitabiotics - UK’s No.1 vitamin company, Gong cha - fast-growing tea brand, and RQD Clearing - strategic growth investment. These investments reflect Bain Capital's commitment to partnering with visionary leaders and driving impactful growth across its portfolio.
Industry
Bain Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Bain Capital Asia Fund V
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Financial Services
Fintech
Healthcare Services
Industrial
Real Estate
|
Series B
Late Stage (Series C+)
|
North America
Europe
Asia
|
$5-10 m
|
$6000 M
|
May 2023
|
|
Bain Capital Insurance fund I
|
Fund of funds
|
Financial Services
Fintech
Healthcare Services
Real Estate
|
Seed
Series A
Series B
|
North America
Europe
Asia
|
$5-10 m
|
$1200 M
|
July 2023
|
|
Bain Capital Europe Fund VI
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
Industrial
Real Estate
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$6400 M
|
October 2023
|
|
Bain Capital Global Special Situations Fund II
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Industrial
Real Estate
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$5700 M
|
November 2024
|
|
Bain Capital Real Estate Fund III
|
Fund of funds
|
Financial Services
Fintech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Software
HealthTech
|
Series A
Series B
|
North America
|
$5-10 m
|
$3400 M
|
January 2026
|
|
Bain Capital Pan-Asia Private Equity Fund VI
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Real Estate
SaaS
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$10500 M
|
March 2026
|
|
Bain Capital Credit CLO Management III
|
Fund of funds
|
Financial Services
Fintech
Healthcare Services
Real Estate
SaaS
Software
HealthTech
|
Seed
Series A
|
North America
|
$5-10 m
|
$1500 M
|
April 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.